New research developing to help identify cancer early
NEW research development may be able to help doctors detect the early stages of cancer.
Chemists from UNSW Sydney's Australian Centre for Nanomedicine and biologists from UNSW's Lowy Cancer Research Centre have just created a Nanopore Blockade Sensor which can analyse diseases and cancer biomarkers at a molecular level.
Professor Justin Gooding said this has been a key approach to reducing deaths from cancers, as it will help with early diagnosis.
"Developing ultra-sensitive cancer marker sensors is critical because it allows for very early detection after the cancer has occurred but before any symptoms start appearing,” he said.
"The best way to cure cancer is to detect and diagnose it early. What this sensor can do is detect biomarkers and single molecules at much lower levels than current blood tests can, and we can get results in several minutes.”
The technology needs to go through difficult further research and trials which can last up to five to 10 years, but this ground-breaking movement will be able to help many in the future.
"This is a really hot area in cancer research, especially as it could potentially have a substantial impact as an effective means to estimate how effective treatment will be and assess how likely it is for cancer to reoccur,” Professor Gooding said.
The Australian Research Council is funding this development through the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology.
This research will be debuted at the International Nanomedicine Conference next week, from June 24 to 26.